News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
210,001 Results
Type
Article (8302)
Company Profile (14)
Press Release (201685)
Multimedia
Podcasts (8)
Webinars (1)
Section
Business (66707)
Career Advice (407)
Deals (12373)
Drug Delivery (23)
Drug Development (28381)
Employer Resources (43)
FDA (4544)
Job Trends (4824)
News (109601)
Policy (8198)
Tag
Academia (478)
Accelerated approval (5)
Adcomms (3)
Allergies (47)
Alliances (8180)
ALS (72)
Alzheimer's disease (562)
Antibody-drug conjugate (ADC) (106)
Approvals (4710)
Artificial intelligence (173)
Autoimmune disease (33)
Automation (13)
Bankruptcy (89)
Best Places to Work (4416)
BIOSECURE Act (2)
Biosimilars (76)
Biotechnology (12)
Bladder cancer (101)
Brain cancer (26)
Breast cancer (304)
Cancer (2202)
Cardiovascular disease (150)
Career advice (338)
Career pathing (1)
CAR-T (91)
CDC (5)
Cell therapy (267)
Cervical cancer (22)
Clinical research (26032)
Collaboration (582)
Company closure (3)
Compensation (390)
Complete response letters (12)
COVID-19 (794)
CRISPR (35)
C-suite (201)
Cystic fibrosis (55)
Data (2715)
Depression (38)
Diabetes (191)
Diagnostics (2047)
Digital health (16)
Diversity (1)
Diversity, equity & inclusion (9)
Drug discovery (73)
Drug pricing (28)
Drug shortages (5)
Duchenne muscular dystrophy (93)
Earnings (54225)
Editorial (4)
Employer branding (8)
Employer resources (35)
Events (39043)
Executive appointments (407)
FDA (5853)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (573)
Gene editing (62)
Generative AI (6)
Gene therapy (199)
GLP-1 (359)
Government (1126)
Grass and pollen (3)
Guidances (318)
Healthcare (5855)
HIV (26)
Huntington's disease (12)
IgA nephropathy (34)
Immunology and inflammation (93)
Immuno-oncology (3)
Indications (29)
Infectious disease (902)
Inflammatory bowel disease (63)
Inflation Reduction Act (1)
Influenza (41)
Intellectual property (73)
Interviews (80)
IPO (7571)
IRA (6)
Job creations (731)
Job search strategy (292)
Kidney cancer (10)
Labor market (26)
Layoffs (165)
Leadership (4)
Legal (1515)
Liver cancer (30)
Longevity (5)
Lung cancer (342)
Lymphoma (160)
Machine learning (14)
Management (11)
Manufacturing (207)
MASH (65)
Medical device (4109)
Medtech (4119)
Mergers & acquisitions (5297)
Metabolic disorders (462)
Multiple sclerosis (67)
NASH (8)
Neurodegenerative disease (78)
Neuropsychiatric disorders (22)
Neuroscience (1011)
NextGen: Class of 2025 (1436)
Non-profit (941)
Now hiring (8)
Obesity (200)
Opinion (45)
Ovarian cancer (82)
Pain (81)
Pancreatic cancer (84)
Parkinson's disease (106)
Partnered (3)
Patents (165)
Patient recruitment (127)
Peanut (23)
People (7128)
Pharmaceutical (7)
Pharmacy benefit managers (6)
Phase I (6984)
Phase II (11101)
Phase III (10000)
Pipeline (1928)
Policy (22)
Postmarket research (1009)
Preclinical (2408)
Press Release (12)
Prostate cancer (128)
Psychedelics (10)
Radiopharmaceuticals (81)
Rare diseases (249)
Real estate (899)
Recruiting (23)
Regulatory (6914)
Reports (19)
Research institute (460)
Resumes & cover letters (58)
Rett syndrome (9)
RNA editing (4)
RSV (32)
Schizophrenia (73)
Series A (85)
Series B (66)
Sickle cell disease (33)
Special edition (7)
Spinal muscular atrophy (46)
Sponsored (2)
Startups (606)
State (1)
Stomach cancer (4)
Supply chain (41)
Tariffs (16)
The Weekly (8)
Vaccines (333)
Venture capital (22)
Weight loss (127)
Women's health (26)
Worklife (5)
Date
Today (88)
Last 7 days (391)
Last 30 days (1275)
Last 365 days (17515)
2025 (13749)
2024 (15672)
2023 (15118)
2022 (18166)
2021 (18192)
2020 (16426)
2019 (13467)
2018 (9720)
2017 (9609)
2016 (8552)
2015 (10865)
2014 (8031)
2013 (5966)
2012 (6452)
2011 (6731)
2010 (5946)
Location
Africa (171)
Alabama (36)
Alaska (2)
Arizona (60)
Arkansas (6)
Asia (12838)
Australia (1857)
California (5037)
Canada (1231)
China (393)
Colorado (195)
Connecticut (247)
Delaware (192)
Europe (29390)
Florida (630)
Georgia (128)
Hawaii (2)
Idaho (11)
Illinois (361)
India (14)
Indiana (228)
Iowa (8)
Japan (214)
Kansas (34)
Kentucky (12)
Louisiana (9)
Maine (46)
Maryland (503)
Massachusetts (3838)
Michigan (109)
Minnesota (249)
Mississippi (3)
Missouri (49)
Montana (8)
Nebraska (3)
Nevada (75)
New Hampshire (31)
New Jersey (1531)
New Mexico (12)
New York (1258)
North Carolina (580)
North Dakota (3)
Northern California (2363)
Ohio (95)
Oklahoma (5)
Oregon (13)
Pennsylvania (936)
Puerto Rico (5)
Rhode Island (14)
South America (284)
South Carolina (10)
Southern California (1860)
Tennessee (58)
Texas (750)
United States (17669)
Utah (161)
Virginia (144)
Washington D.C. (32)
Washington State (472)
West Virginia (1)
Wisconsin (64)
210,001 Results for "8".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Weight Management Market Size to Surpass USD 59.8 Billion by 2032 | Growing at 7.8% CAGR
October 17, 2025
·
1 min read
Now Hiring
8 Companies Hiring in San Francisco
Looking for a biopharma job in San Francisco or South San Francisco? Check out the
BioSpace
list of eight companies hiring life sciences professionals like you.
August 28, 2025
·
1 min read
·
Chantal Dresner
Press Releases
Incyte to Report Third Quarter Financial Results - October 8, 2025
October 9, 2025
·
1 min read
Mergers & acquisitions
Genmab Buys Rising Cancer Star Merus for $8B
The centerpiece of the acquisition is petosemtamab, Merus’ bispecific antibody targeting EGFR and LGR5, which in May demonstrated best-in-class potential for head-and-neck cancer.
September 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
October 8, 2025
·
5 min read
Press Releases
Inventiva to Host Analyst and Investor Event on October 8, 2025
September 25, 2025
·
2 min read
Press Releases
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
September 29, 2025
·
4 min read
Press Releases
BioVie to Host Live Investor Webinar and Q&A on Oct. 8
September 29, 2025
·
3 min read
Press Releases
Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel
October 15, 2025
·
4 min read
Press Releases
AB Science announces the successful completion of a EUR 2.8 million private placement
October 17, 2025
·
11 min read
1 of 21,001
Next
